Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

1.5K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

602
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

566
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

405
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

399
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
399
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

695
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Will these shirts protect you from Zika? With fears on the rise we put treated clothing to the test.

Consumer reports·2016
Same author

The Acupuncture Myth.

Scientific American·2016
Same author

Insect Repellents in the Age of Zika. Our new tests identify what works and what doesn't against the bugs that can spread the virus and other serious diseases.

Consumer reports·2016
Same author

The Paradox of Precision Medicine.

Scientific American·2016
Same author

Breaking the brain barrier.

Scientific American·2013
Same author

Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V.

Immunity·2012
Same journal

The Safest Car Seat for Your Child.

Consumer reports·2016
Same journal

Zero Tolerance.

Consumer reports·2016
Same journal

Colon cancer runs in my family: Should I get a genetic test? I worry that'll affect my insurance.

Consumer reports·2016
Same journal

How to Survive a High-Deductible Health Plan. Is your insurance giving you a bad case of sticker shock? Here are ways to ease the pain.

Consumer reports·2016
Same journal

Your Health Is Priceless.

Consumer reports·2016
Same journal

Fighting Merger Mania in Health Insurance.

Consumer reports·2016
See all related articles

Related Experiment Video

Updated: Mar 10, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.2K

An Essential Heart-Surgery Device Has a Rare But Deadly Side Effect.

Jeneen Interlandi

    Consumer Reports
    |December 18, 2016
    PubMed
    Summary
    This summary is machine-generated.

    A new infection risk has been identified in open chest surgeries. Patients should stay informed about this surgical site infection threat and protective measures.

    More Related Videos

    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    25.3K
    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
    23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    84.7K

    Related Experiment Videos

    Last Updated: Mar 10, 2026

    Implantation of the Syncardia Total Artificial Heart
    16:11

    Implantation of the Syncardia Total Artificial Heart

    Published on: July 18, 2014

    36.2K
    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    25.3K
    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
    23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    84.7K

    Area of Science:

    • Medical Science
    • Infectious Diseases
    • Surgical Safety

    Background:

    • Hospitals and federal agencies are addressing a novel infection risk.
    • This risk is associated with patients undergoing open chest surgeries.
    • Patient safety during surgical procedures is a primary concern.

    Purpose of the Study:

    • To inform patients about a newly discovered infection risk.
    • To provide guidance on self-protection measures for patients.
    • To ensure transparency regarding surgical procedure safety.

    Main Methods:

    • This study involves the analysis of recent infection data.
    • It synthesizes information from hospital and federal health agencies.
    • The findings are based on current epidemiological surveillance.

    Main Results:

    • A previously unrecognized infection risk has been identified.
    • The risk is linked to the specific procedures involved in open chest surgeries.
    • Data suggests a need for immediate management strategies.

    Conclusions:

    • Patients undergoing open chest surgery face a new infection risk.
    • Proactive patient awareness and protective actions are crucial.
    • Ongoing vigilance and updated protocols are necessary to mitigate this risk.